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Changes in the rdaiive a’Funber.ce c? tAc G p:ctein 2 :ubunits x::c &ilxfid i!uikg early filixl.?s dtva:spmcz:t G, :v3s almos! cxc!l2!sirr!y pmPn! 
as a large form (G,,) in prenatal brain. Postnatally with a substantial increase in GppwH]p stimulated adenylyl cyclase activity, the small form 
(G, J increawd in amount while G,., decreased. These results uggest that the G,, may be the more effective cyclase activator and that changes 
in alternative splicing are developmentally regulated. Gil and G, appeared before birth whereas G, developed postnatally. Opiate stimulation of 
GTPase and inhibition of adenylyl cyclase were fully expressed prenatally. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
The heterotrimeric G proteins mediate signal 
transduction across cell membranes; they are activated 
by extracellular eceptors and subsequently modulate 
the activities of intracellular proteins responsible for 
second messenger production or ion channel control 
[l-3]. Adenylyl cyclase is subject o stimulatory control 
by receptors acting through G, and inhibitory modula- 
tion by those working through a Gi. Four different G, 
a-subunits of two major size classes are known to be 
generated by alternative splicing of a single precursor 
gene [4-61. There are also a number of Gi species, many 
of which are products of different genes [7-91. The ma- 
jor Gi species found in brain are G,, G-i, and Giz 
[lo- 121. One or more of these proteins is responsible for 
coupling inhibitory receptors to adenylyl cyclase [l-3]. 
Here we report studies in which we measured the 
amounts of the G protein cu-subunits present during 
pre- and early postnatal development of the mouse 
brain together with Gpp[NH]p stimulation of adenylyl 
cyclase as a measure of G, activity, and opiate inhibi- 
tion of adenylyl cyclase and stimulation of low K,,, 
GTPase to address Gi functionality. 
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AD6reviarians: G proteins (G,, Gil, Gia and Gn), guanine nuclcotidc 
regulatory proteins; E, embryonic day; EGTA, [cthylcncbis(ox- 
ycthylcnctrilo)]tctracclic acid; SDS-PAGE, sodium dodccyl sulfabz- 
polyacrylamidc gel elcctrophorcsis; Gpp[NH]p, guanyl-5’-yl- 
illiidodipllosplintc; TBST, O.OS% ‘fwccn in Tris-bufrcrcd saline 
2. I. Animals orrd !issue pn?parotion 
Adult male and female NIH white mice (NCI, Frederick) were 
mated by placing one male with four females for It-14 hours; males 
were then removed and this moment was considered as embryonic day 
0.5. Pregnant females were euthanized by cervical dislocation follow- 
ed by decapitation at different stages of the embryonic development; 
similar procedures were used in postnatal days. Brains were 
homogenized in 20 vols of 0.32 M sucrose. Samples were centrifuged 
at 1000 x g for IO min; the supernatant suspensions were centrifuged 
at 48000 x g for I5 min and the pellets were resuspended and washed 
twice in 50 vols of 2 mM Tris (pH 7.4), 2 mM EGTA. 
2.2. Western blots 
Membrane fractions p-epared RS above were treated as described by 
Sternweis and Robishaw [lo]; samples were separated by SDS-PAGE 
[13] and transfcrrcd to nitrocellulose membranes using a Sartorius 
semi-dry elcctroblottcr [14]. Blots were incubated at room 
temperature with I% gelatin in TBST (20 mM Tris-HCI (pH 7.S), 500 
mM NaCl and 0.05% Tween 20) for I h, washed 3 times for 10 min 
with TBST, and incubated with the appropriate antibody for 2 h. G, 
was reacted with antibody RM (1:750) [ 151 or in other experiments by 
anti-GI antibody 584 (1:lOOO) [2] was used with similar results. This 
antiserum recognized proteins with apparent molecular weights of 
46000 for G,.l and 42 300 for G,.%, in a IO-12.5% polyacrylamide gel 
using high molecular weight rainbow markers (Amcrsham). GII was 
quantitatcd with antibodies AS/7 (1:lOO) [16] and LD (2icg/ml) 117); 
GIZ by antibodies AS/7 and LE (5 &ml) 116); Ga by antibody Go/l 
[12]. Blots wcrc washed 3 times over IO min with TBST and then in- 
cubatcd with [‘2’l]Protcin A (100OOOcpm/ml) for 30 min followed by 
3 washes of IO min. Blots were then cxposcd to Kodak AR2 film for 
4-16 h I The outoradiograms were analyzed by dcnsitometry of images 
gcncratcd by a tclcvision camera intcrfaccd with a Macintosh II com- 
putcr using the program IMAGE dcvclopcd by Wayne Rasband (IS]. 
The linearity of ~hcslgnal density and film saturation wcrc monitored 
by using different amounts of mcmbranc protein on the same gel, 
2.3. Adcn~Vyl cycla.rc and GTPase nIcaswi?lneno 
For Gpp/N?f]p stirtrolatcd adcn&l wlasc, pcllc~s wcrc rcsuspcnd- 
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ed in 2 mM Tris (pH 7.4), 2 mM EGTA at approximately 5 mg 
prot./ml. The reactions contained 50 pl of membranes in a final 
volume of 250~1 in the presence of 25 mM Tris-HCI (pH 7.4), I mM 
isobutylmethylxanthinc, 2 mM MgClz, 0.4 mM EGTA. 10 mM 
crcatinephosphate, 25 U of creatine kinase and 0.5 mM ATP. After 
10 min at 37’C, the reaction was stopped by the addition of 10,uI of 
0.5 M EDTA and boiling for 5 min. CAMP was measured by radioim- 
munoassay with a commercially available kit (NEN). Opiule sensitive 
odeny/y/ cychse activity was mcascred by a modification [19] of the 
method of Salomon et al. [to]. For these analyses membranes were 
prepared from brain homogenates in 0.32 M sucrose at 1-2 mg 
prot./ml. The homogenate was centrifuged at 1000 x g for 10 min and 
the supernatant suspension was centrifuged for 20 min at 48OOOxg. 
The pelleted membranes were suspended at I-2 mg prot./ml in 0.32 
M sucrose, IO mM Tris-HCI (pH 8) and stored in aliquots at - 7CW. 
2Opg protein were used in each assay. Etorphine effects were showr 
to be reversed by naloxone. Other opiates tested, including B- and d- 
selective opioid peptides, were less effective than etorphine with 
developing mouse brain membranes. 
Low K,, GTPuse activity was measured by a modification [21] of 
the method of Casscl and Selinger [22]. GTPasc measurements were 
performed with 5 fig protein per sample. 
2.4. Profein assay 
Protein content was determined by a dye binding assay 1231 from 
Bio-Rad or by the method of Lowry et al. [24]. 
-- 
3. RESULTS AND DISCUSSION 
The amounts of G protein a-subunits present in brain 
membranes were measured by quantitative im- 
munoblotting. Antibodies specific for G, recognized the 
large and small forms of the protein (Fig. 1A). In- 
terestingly, the amount of G+I was more than twice that 
of adult at embryonic days 14.5-16.5, whereas G,., was 
less than 10% of adult prior to Elk.5 (Fig. IB). The 
amount of Gs.l decreased as C&S increased late in 
development. Gs levels were close to those of the adult 
at postnatal day 14, at which time the concentrations of
t.he large and small forms in whole brain membranes 
were similar. The reciprocal relationship between the 
amounts of the two species found during development 
suggests that a change in the alternative splicing 
mechanism occurred late in development. A similar fin- 
ding has recently been reported in brown adipose tissue, 
in which it was established that the ratio of the protein 
forms directly reflects that of the mRNA [25J. It will be 
of interest o see whether the alternatively spliced forms 
of G, [26,27] develop in parallel to those of G,. 
We measured the extent of guanine nucleotide 
stimulation of adenylyl cyclase in brain membranes of 
various developmental stages. The GTP analogue 
Gpp[NH]p stimulated adenylyl cyclase approximately 
3-fold between embryonic days 12.5 and 16.5 but at 
E18.5 the amount of stimulation started to rise towards 
the adult level of 5 to 6-fold (Fig. 2). Reconstitution ex- 
periments with individually expressed Gx.l and G,., 
forms have shown that the larger species were activated 
more rapidly, but that they also had a higher intrinsic 
GTPasc activity [28,29], Our results are consistent with 
several observations that most hormonal stimulation of 
adcnylyl cyclase develops postnatnlly [30-321, and sug- 
52 
(Al 
14 16 18 1 3 7 14 ADULT 
EMBRYONIC DAY POSTNATAL DAY 
T 
_- i 
-0 
_- _+-._----- 
c 
6- 
04 I I 1 , 
IA.6 16.5 10.5 I 3 7 14 
EflBYONlC DAY POST NATAL DAY 
Fig. I.A. lmmunoblot analysis of Gs.l and rZr in mouse brain mem- 
branes (2Spg protein) from pre- and postnatal development. Samples 
were subject to a 12.5% SDS-PAGE system and transferred to 
nitrocellulose membranes as described in section 2. For this blot the 
G, RM antibody (1:750) was used. B. Densitometric analysis of 
autoradiograms showing the ontogeny of G, subunits in mouse brain 
membranes. The data represent mean f. SD of at least 3 separate gels 
from no less than 3 different pools of animals at each age. 
gest that G,., species may be primarily associated with 
hormonal activation of adenylate cyclase, as shown for 
HIT cells [33]; whereas G+I species may serve addi- 
tional roles as well [34]. 
The a-subunits of Gil and Go [35,36] showed an 
almost linear increase throughout he prenatal develop- 
ment of the brain (Fig. 3A and B) whereas Giz was not 
2000, 
I -o_ ala01 -+- GPPWIP 1 
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Fig, 2. Dcvclopment of adcnylyl cyclase activity in synnp~oson~al 
mctnbranc preparation of rnousc brain. CAMP fortnatiotl was 
measured in the ;~bsct~cc (O-0) or prcscncc of IO /r&l Cipp[NH]p 
(M). Each point is the mm +SD of 3 or 4 cxpcrimcnts pcrform- 
cd in trlpllcatc. 
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Fig. 3. lmmunoblot analysis of the appearance of Gil and Giz (A) and 
G, (B) during early mouse brain development. Values are the 
mean t SD of 2-G determinations at each age. 
present in appreciable amounts prior to birth (Fig. 3A). 
To assess the functional significance of these 
developmental profiIes, stimulation of GTPase activity 
by the potent, and receptor subtype unselective opiate 
etorphine was measured. Stimulation of GTPase was 
detectable at E12.5, and reached adult levels by E18.5 
(Fig. 4A). This developmental profile did not corres- 
pond with that of any of the G proteins measured 
(Fig. 3) and suggests that it is the receptor which is 
limiting in early development. Several studies of opiate 
receptors in rodent brain [37-401 showed that ,u- 
receptors are fully developed at E14.5 and that 6 are 
found only after birth, but that x-opiate receptors 
which are detectable by E14.5 reach adult levels by 
E16.5 [40]. Thus, there is a good correlation between 
the times of development of x-receptors and of opiate 
stimulated GTPase activity. We do not know the nature 
of all of the opiate sensitive ffector systems operating 
prenatally, but measurements of adenylyl cyclase in- 
hibition of etorphine showed that inhibition was pre- 
sent as early as E12.5, and reached adult levels near 
E15.5 (Fig. 4B). It had been shown ear!ier thatkf-opiate 
receptors account for only a small fraction of opiate in- 
hibition of adenylyl cyclase in neonatal rat brain [40]. 
Thus, x-opiate receptors, which are known to inhibit 
adenylyl cyclase in spinal cord [42J, may mediate the 
bulk of opiate stimulation of GTPase and inhibition of 
adenylate cyclase in developing brain, Interestingly, 
cr2-adrenergic receptors which mediate inhibition of 
ndenylyl cyclase [43], are also developed primarily dur- 
ing the prenatal period (441. 
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Fig. 4. Effects of I pM etorphine upon low K,,, GTPase (A) and 
adenylyl cyclase (B) activities of mouse brain membranes during 
development. Assays were performed in pentuplicate and the results 
are presented as meant SEM. 
Adenylyl cyclase activity is controlled both by 
stimulatory and inhibitory hormone receptors. Our 
results suggest hat the brain enzyme may be relativeIy 
refractory to stimulatory hormone action prior to birth 
because G,., has not yet developed, but that inhibitory 
hormone control of its activity is present. Thus, it may 
be important to keep CAMP levels low during this 
period of rapid cell division. Other activities of Gi- 
coupled receptors, such as the control of ion channels 
and phospholipid metabolism, may also play central 
roles in the early control of brain maturation. 
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